Global Mammalian Biologics CDMO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Mammalian Biologics CDMO Services market size was valued at US$ 4554 million in 2024 and is forecast to a readjusted size of USD 8410 million by 2031 with a CAGR of 9.2% during review period.
Mammalian Biologics CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer development, manufacturing, and production support for biologic drugs derived from mammalian cell cultures. These services are critical for the production of biologics, which are complex, biologically-derived therapeutic products, including monoclonal antibodies (mAbs), vaccines, therapeutic proteins, and cell and gene therapies.
This report is a detailed and comprehensive analysis for global Mammalian Biologics CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mammalian Biologics CDMO Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mammalian Biologics CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mammalian Biologics CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific, AGC Biologics, Rentschler Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Mammalian Biologics CDMO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Mammalian Biologics CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Mammalian Biologics CDMO Services, with revenue, gross margin, and global market share of Mammalian Biologics CDMO Services from 2020 to 2025.
Chapter 3, the Mammalian Biologics CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Mammalian Biologics CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mammalian Biologics CDMO Services.
Chapter 13, to describe Mammalian Biologics CDMO Services research findings and conclusion.
Mammalian Biologics CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer development, manufacturing, and production support for biologic drugs derived from mammalian cell cultures. These services are critical for the production of biologics, which are complex, biologically-derived therapeutic products, including monoclonal antibodies (mAbs), vaccines, therapeutic proteins, and cell and gene therapies.
This report is a detailed and comprehensive analysis for global Mammalian Biologics CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mammalian Biologics CDMO Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Mammalian Biologics CDMO Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mammalian Biologics CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mammalian Biologics CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, WuXi AppTech, Recipharm, Thermo Fisher Scientific, AGC Biologics, Rentschler Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Mammalian Biologics CDMO Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cell and Gene Therapies
- Antibodies
- Vaccines
- Other
- SMBs
- Large Companies
- Lonza
- Catalent
- Samsung Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- WuXi AppTech
- Recipharm
- Thermo Fisher Scientific
- AGC Biologics
- Rentschler Biopharma
- KBI Biopharma
- Siegfried
- Aenova Group
- GenScript
- ProBioGen
- Northway Biotech
- 3P Biopharmaceuticals
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Mammalian Biologics CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Mammalian Biologics CDMO Services, with revenue, gross margin, and global market share of Mammalian Biologics CDMO Services from 2020 to 2025.
Chapter 3, the Mammalian Biologics CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Mammalian Biologics CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mammalian Biologics CDMO Services.
Chapter 13, to describe Mammalian Biologics CDMO Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Mammalian Biologics CDMO Services by Type
1.3.1 Overview: Global Mammalian Biologics CDMO Services Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Mammalian Biologics CDMO Services Consumption Value Market Share by Type in 2024
1.3.3 Cell and Gene Therapies
1.3.4 Antibodies
1.3.5 Vaccines
1.3.6 Other
1.4 Global Mammalian Biologics CDMO Services Market by Application
1.4.1 Overview: Global Mammalian Biologics CDMO Services Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 SMBs
1.4.3 Large Companies
1.5 Global Mammalian Biologics CDMO Services Market Size & Forecast
1.6 Global Mammalian Biologics CDMO Services Market Size and Forecast by Region
1.6.1 Global Mammalian Biologics CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Mammalian Biologics CDMO Services Market Size by Region, (2020-2031)
1.6.3 North America Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.4 Europe Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.6 South America Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Mammalian Biologics CDMO Services Product and Solutions
2.1.4 Lonza Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Mammalian Biologics CDMO Services Product and Solutions
2.2.4 Catalent Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Samsung Biologics
2.3.1 Samsung Biologics Details
2.3.2 Samsung Biologics Major Business
2.3.3 Samsung Biologics Mammalian Biologics CDMO Services Product and Solutions
2.3.4 Samsung Biologics Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Samsung Biologics Recent Developments and Future Plans
2.4 FUJIFILM Diosynth Biotechnologies
2.4.1 FUJIFILM Diosynth Biotechnologies Details
2.4.2 FUJIFILM Diosynth Biotechnologies Major Business
2.4.3 FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Product and Solutions
2.4.4 FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Mammalian Biologics CDMO Services Product and Solutions
2.5.4 Boehringer Ingelheim Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 WuXi AppTech
2.6.1 WuXi AppTech Details
2.6.2 WuXi AppTech Major Business
2.6.3 WuXi AppTech Mammalian Biologics CDMO Services Product and Solutions
2.6.4 WuXi AppTech Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 WuXi AppTech Recent Developments and Future Plans
2.7 Recipharm
2.7.1 Recipharm Details
2.7.2 Recipharm Major Business
2.7.3 Recipharm Mammalian Biologics CDMO Services Product and Solutions
2.7.4 Recipharm Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Recipharm Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Mammalian Biologics CDMO Services Product and Solutions
2.8.4 Thermo Fisher Scientific Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 AGC Biologics
2.9.1 AGC Biologics Details
2.9.2 AGC Biologics Major Business
2.9.3 AGC Biologics Mammalian Biologics CDMO Services Product and Solutions
2.9.4 AGC Biologics Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 AGC Biologics Recent Developments and Future Plans
2.10 Rentschler Biopharma
2.10.1 Rentschler Biopharma Details
2.10.2 Rentschler Biopharma Major Business
2.10.3 Rentschler Biopharma Mammalian Biologics CDMO Services Product and Solutions
2.10.4 Rentschler Biopharma Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Rentschler Biopharma Recent Developments and Future Plans
2.11 KBI Biopharma
2.11.1 KBI Biopharma Details
2.11.2 KBI Biopharma Major Business
2.11.3 KBI Biopharma Mammalian Biologics CDMO Services Product and Solutions
2.11.4 KBI Biopharma Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 KBI Biopharma Recent Developments and Future Plans
2.12 Siegfried
2.12.1 Siegfried Details
2.12.2 Siegfried Major Business
2.12.3 Siegfried Mammalian Biologics CDMO Services Product and Solutions
2.12.4 Siegfried Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Siegfried Recent Developments and Future Plans
2.13 Aenova Group
2.13.1 Aenova Group Details
2.13.2 Aenova Group Major Business
2.13.3 Aenova Group Mammalian Biologics CDMO Services Product and Solutions
2.13.4 Aenova Group Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Aenova Group Recent Developments and Future Plans
2.14 GenScript
2.14.1 GenScript Details
2.14.2 GenScript Major Business
2.14.3 GenScript Mammalian Biologics CDMO Services Product and Solutions
2.14.4 GenScript Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 GenScript Recent Developments and Future Plans
2.15 ProBioGen
2.15.1 ProBioGen Details
2.15.2 ProBioGen Major Business
2.15.3 ProBioGen Mammalian Biologics CDMO Services Product and Solutions
2.15.4 ProBioGen Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 ProBioGen Recent Developments and Future Plans
2.16 Northway Biotech
2.16.1 Northway Biotech Details
2.16.2 Northway Biotech Major Business
2.16.3 Northway Biotech Mammalian Biologics CDMO Services Product and Solutions
2.16.4 Northway Biotech Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Northway Biotech Recent Developments and Future Plans
2.17 3P Biopharmaceuticals
2.17.1 3P Biopharmaceuticals Details
2.17.2 3P Biopharmaceuticals Major Business
2.17.3 3P Biopharmaceuticals Mammalian Biologics CDMO Services Product and Solutions
2.17.4 3P Biopharmaceuticals Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 3P Biopharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Mammalian Biologics CDMO Services Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Mammalian Biologics CDMO Services by Company Revenue
3.2.2 Top 3 Mammalian Biologics CDMO Services Players Market Share in 2024
3.2.3 Top 6 Mammalian Biologics CDMO Services Players Market Share in 2024
3.3 Mammalian Biologics CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Mammalian Biologics CDMO Services Market: Region Footprint
3.3.2 Mammalian Biologics CDMO Services Market: Company Product Type Footprint
3.3.3 Mammalian Biologics CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Mammalian Biologics CDMO Services Consumption Value and Market Share by Type (2020-2025)
4.2 Global Mammalian Biologics CDMO Services Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2025)
5.2 Global Mammalian Biologics CDMO Services Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
6.2 North America Mammalian Biologics CDMO Services Market Size by Application (2020-2031)
6.3 North America Mammalian Biologics CDMO Services Market Size by Country
6.3.1 North America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
6.3.2 United States Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
6.3.3 Canada Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
6.3.4 Mexico Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
7.2 Europe Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
7.3 Europe Mammalian Biologics CDMO Services Market Size by Country
7.3.1 Europe Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
7.3.2 Germany Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.3 France Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.5 Russia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.6 Italy Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Mammalian Biologics CDMO Services Market Size by Region
8.3.1 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2020-2031)
8.3.2 China Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.3 Japan Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.4 South Korea Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.5 India Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.7 Australia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
9.2 South America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
9.3 South America Mammalian Biologics CDMO Services Market Size by Country
9.3.1 South America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
9.3.3 Argentina Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Mammalian Biologics CDMO Services Market Size by Country
10.3.1 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10.3.4 UAE Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Mammalian Biologics CDMO Services Market Drivers
11.2 Mammalian Biologics CDMO Services Market Restraints
11.3 Mammalian Biologics CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Mammalian Biologics CDMO Services Industry Chain
12.2 Mammalian Biologics CDMO Services Upstream Analysis
12.3 Mammalian Biologics CDMO Services Midstream Analysis
12.4 Mammalian Biologics CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Mammalian Biologics CDMO Services by Type
1.3.1 Overview: Global Mammalian Biologics CDMO Services Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Mammalian Biologics CDMO Services Consumption Value Market Share by Type in 2024
1.3.3 Cell and Gene Therapies
1.3.4 Antibodies
1.3.5 Vaccines
1.3.6 Other
1.4 Global Mammalian Biologics CDMO Services Market by Application
1.4.1 Overview: Global Mammalian Biologics CDMO Services Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 SMBs
1.4.3 Large Companies
1.5 Global Mammalian Biologics CDMO Services Market Size & Forecast
1.6 Global Mammalian Biologics CDMO Services Market Size and Forecast by Region
1.6.1 Global Mammalian Biologics CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Mammalian Biologics CDMO Services Market Size by Region, (2020-2031)
1.6.3 North America Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.4 Europe Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.6 South America Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Mammalian Biologics CDMO Services Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Mammalian Biologics CDMO Services Product and Solutions
2.1.4 Lonza Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Mammalian Biologics CDMO Services Product and Solutions
2.2.4 Catalent Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Samsung Biologics
2.3.1 Samsung Biologics Details
2.3.2 Samsung Biologics Major Business
2.3.3 Samsung Biologics Mammalian Biologics CDMO Services Product and Solutions
2.3.4 Samsung Biologics Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Samsung Biologics Recent Developments and Future Plans
2.4 FUJIFILM Diosynth Biotechnologies
2.4.1 FUJIFILM Diosynth Biotechnologies Details
2.4.2 FUJIFILM Diosynth Biotechnologies Major Business
2.4.3 FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Product and Solutions
2.4.4 FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Mammalian Biologics CDMO Services Product and Solutions
2.5.4 Boehringer Ingelheim Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 WuXi AppTech
2.6.1 WuXi AppTech Details
2.6.2 WuXi AppTech Major Business
2.6.3 WuXi AppTech Mammalian Biologics CDMO Services Product and Solutions
2.6.4 WuXi AppTech Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 WuXi AppTech Recent Developments and Future Plans
2.7 Recipharm
2.7.1 Recipharm Details
2.7.2 Recipharm Major Business
2.7.3 Recipharm Mammalian Biologics CDMO Services Product and Solutions
2.7.4 Recipharm Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Recipharm Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Mammalian Biologics CDMO Services Product and Solutions
2.8.4 Thermo Fisher Scientific Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 AGC Biologics
2.9.1 AGC Biologics Details
2.9.2 AGC Biologics Major Business
2.9.3 AGC Biologics Mammalian Biologics CDMO Services Product and Solutions
2.9.4 AGC Biologics Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 AGC Biologics Recent Developments and Future Plans
2.10 Rentschler Biopharma
2.10.1 Rentschler Biopharma Details
2.10.2 Rentschler Biopharma Major Business
2.10.3 Rentschler Biopharma Mammalian Biologics CDMO Services Product and Solutions
2.10.4 Rentschler Biopharma Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Rentschler Biopharma Recent Developments and Future Plans
2.11 KBI Biopharma
2.11.1 KBI Biopharma Details
2.11.2 KBI Biopharma Major Business
2.11.3 KBI Biopharma Mammalian Biologics CDMO Services Product and Solutions
2.11.4 KBI Biopharma Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 KBI Biopharma Recent Developments and Future Plans
2.12 Siegfried
2.12.1 Siegfried Details
2.12.2 Siegfried Major Business
2.12.3 Siegfried Mammalian Biologics CDMO Services Product and Solutions
2.12.4 Siegfried Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Siegfried Recent Developments and Future Plans
2.13 Aenova Group
2.13.1 Aenova Group Details
2.13.2 Aenova Group Major Business
2.13.3 Aenova Group Mammalian Biologics CDMO Services Product and Solutions
2.13.4 Aenova Group Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Aenova Group Recent Developments and Future Plans
2.14 GenScript
2.14.1 GenScript Details
2.14.2 GenScript Major Business
2.14.3 GenScript Mammalian Biologics CDMO Services Product and Solutions
2.14.4 GenScript Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 GenScript Recent Developments and Future Plans
2.15 ProBioGen
2.15.1 ProBioGen Details
2.15.2 ProBioGen Major Business
2.15.3 ProBioGen Mammalian Biologics CDMO Services Product and Solutions
2.15.4 ProBioGen Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 ProBioGen Recent Developments and Future Plans
2.16 Northway Biotech
2.16.1 Northway Biotech Details
2.16.2 Northway Biotech Major Business
2.16.3 Northway Biotech Mammalian Biologics CDMO Services Product and Solutions
2.16.4 Northway Biotech Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Northway Biotech Recent Developments and Future Plans
2.17 3P Biopharmaceuticals
2.17.1 3P Biopharmaceuticals Details
2.17.2 3P Biopharmaceuticals Major Business
2.17.3 3P Biopharmaceuticals Mammalian Biologics CDMO Services Product and Solutions
2.17.4 3P Biopharmaceuticals Mammalian Biologics CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 3P Biopharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Mammalian Biologics CDMO Services Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Mammalian Biologics CDMO Services by Company Revenue
3.2.2 Top 3 Mammalian Biologics CDMO Services Players Market Share in 2024
3.2.3 Top 6 Mammalian Biologics CDMO Services Players Market Share in 2024
3.3 Mammalian Biologics CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Mammalian Biologics CDMO Services Market: Region Footprint
3.3.2 Mammalian Biologics CDMO Services Market: Company Product Type Footprint
3.3.3 Mammalian Biologics CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Mammalian Biologics CDMO Services Consumption Value and Market Share by Type (2020-2025)
4.2 Global Mammalian Biologics CDMO Services Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2025)
5.2 Global Mammalian Biologics CDMO Services Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
6.2 North America Mammalian Biologics CDMO Services Market Size by Application (2020-2031)
6.3 North America Mammalian Biologics CDMO Services Market Size by Country
6.3.1 North America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
6.3.2 United States Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
6.3.3 Canada Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
6.3.4 Mexico Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
7.2 Europe Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
7.3 Europe Mammalian Biologics CDMO Services Market Size by Country
7.3.1 Europe Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
7.3.2 Germany Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.3 France Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.5 Russia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
7.3.6 Italy Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Mammalian Biologics CDMO Services Market Size by Region
8.3.1 Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2020-2031)
8.3.2 China Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.3 Japan Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.4 South Korea Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.5 India Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
8.3.7 Australia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
9.2 South America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
9.3 South America Mammalian Biologics CDMO Services Market Size by Country
9.3.1 South America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
9.3.3 Argentina Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Mammalian Biologics CDMO Services Market Size by Country
10.3.1 Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
10.3.4 UAE Mammalian Biologics CDMO Services Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Mammalian Biologics CDMO Services Market Drivers
11.2 Mammalian Biologics CDMO Services Market Restraints
11.3 Mammalian Biologics CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Mammalian Biologics CDMO Services Industry Chain
12.2 Mammalian Biologics CDMO Services Upstream Analysis
12.3 Mammalian Biologics CDMO Services Midstream Analysis
12.4 Mammalian Biologics CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Mammalian Biologics CDMO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Mammalian Biologics CDMO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Mammalian Biologics CDMO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Mammalian Biologics CDMO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Mammalian Biologics CDMO Services Product and Solutions
Table 8. Lonza Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Mammalian Biologics CDMO Services Product and Solutions
Table 13. Catalent Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 16. Samsung Biologics Major Business
Table 17. Samsung Biologics Mammalian Biologics CDMO Services Product and Solutions
Table 18. Samsung Biologics Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 20. FUJIFILM Diosynth Biotechnologies Major Business
Table 21. FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Product and Solutions
Table 22. FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 24. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 25. Boehringer Ingelheim Major Business
Table 26. Boehringer Ingelheim Mammalian Biologics CDMO Services Product and Solutions
Table 27. Boehringer Ingelheim Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Boehringer Ingelheim Recent Developments and Future Plans
Table 29. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 30. WuXi AppTech Major Business
Table 31. WuXi AppTech Mammalian Biologics CDMO Services Product and Solutions
Table 32. WuXi AppTech Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. WuXi AppTech Recent Developments and Future Plans
Table 34. Recipharm Company Information, Head Office, and Major Competitors
Table 35. Recipharm Major Business
Table 36. Recipharm Mammalian Biologics CDMO Services Product and Solutions
Table 37. Recipharm Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Recipharm Recent Developments and Future Plans
Table 39. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 40. Thermo Fisher Scientific Major Business
Table 41. Thermo Fisher Scientific Mammalian Biologics CDMO Services Product and Solutions
Table 42. Thermo Fisher Scientific Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Thermo Fisher Scientific Recent Developments and Future Plans
Table 44. AGC Biologics Company Information, Head Office, and Major Competitors
Table 45. AGC Biologics Major Business
Table 46. AGC Biologics Mammalian Biologics CDMO Services Product and Solutions
Table 47. AGC Biologics Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. AGC Biologics Recent Developments and Future Plans
Table 49. Rentschler Biopharma Company Information, Head Office, and Major Competitors
Table 50. Rentschler Biopharma Major Business
Table 51. Rentschler Biopharma Mammalian Biologics CDMO Services Product and Solutions
Table 52. Rentschler Biopharma Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Rentschler Biopharma Recent Developments and Future Plans
Table 54. KBI Biopharma Company Information, Head Office, and Major Competitors
Table 55. KBI Biopharma Major Business
Table 56. KBI Biopharma Mammalian Biologics CDMO Services Product and Solutions
Table 57. KBI Biopharma Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. KBI Biopharma Recent Developments and Future Plans
Table 59. Siegfried Company Information, Head Office, and Major Competitors
Table 60. Siegfried Major Business
Table 61. Siegfried Mammalian Biologics CDMO Services Product and Solutions
Table 62. Siegfried Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Siegfried Recent Developments and Future Plans
Table 64. Aenova Group Company Information, Head Office, and Major Competitors
Table 65. Aenova Group Major Business
Table 66. Aenova Group Mammalian Biologics CDMO Services Product and Solutions
Table 67. Aenova Group Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Aenova Group Recent Developments and Future Plans
Table 69. GenScript Company Information, Head Office, and Major Competitors
Table 70. GenScript Major Business
Table 71. GenScript Mammalian Biologics CDMO Services Product and Solutions
Table 72. GenScript Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. GenScript Recent Developments and Future Plans
Table 74. ProBioGen Company Information, Head Office, and Major Competitors
Table 75. ProBioGen Major Business
Table 76. ProBioGen Mammalian Biologics CDMO Services Product and Solutions
Table 77. ProBioGen Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. ProBioGen Recent Developments and Future Plans
Table 79. Northway Biotech Company Information, Head Office, and Major Competitors
Table 80. Northway Biotech Major Business
Table 81. Northway Biotech Mammalian Biologics CDMO Services Product and Solutions
Table 82. Northway Biotech Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Northway Biotech Recent Developments and Future Plans
Table 84. 3P Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 85. 3P Biopharmaceuticals Major Business
Table 86. 3P Biopharmaceuticals Mammalian Biologics CDMO Services Product and Solutions
Table 87. 3P Biopharmaceuticals Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. 3P Biopharmaceuticals Recent Developments and Future Plans
Table 89. Global Mammalian Biologics CDMO Services Revenue (USD Million) by Players (2020-2025)
Table 90. Global Mammalian Biologics CDMO Services Revenue Share by Players (2020-2025)
Table 91. Breakdown of Mammalian Biologics CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Mammalian Biologics CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Mammalian Biologics CDMO Services Players
Table 94. Mammalian Biologics CDMO Services Market: Company Product Type Footprint
Table 95. Mammalian Biologics CDMO Services Market: Company Product Application Footprint
Table 96. Mammalian Biologics CDMO Services New Market Entrants and Barriers to Market Entry
Table 97. Mammalian Biologics CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Mammalian Biologics CDMO Services Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Mammalian Biologics CDMO Services Consumption Value Share by Type (2020-2025)
Table 100. Global Mammalian Biologics CDMO Services Consumption Value Forecast by Type (2026-2031)
Table 101. Global Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025)
Table 102. Global Mammalian Biologics CDMO Services Consumption Value Forecast by Application (2026-2031)
Table 103. North America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Mammalian Biologics CDMO Services Upstream (Raw Materials)
Table 134. Global Mammalian Biologics CDMO Services Typical Customers
Table 1. Global Mammalian Biologics CDMO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Mammalian Biologics CDMO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Mammalian Biologics CDMO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Mammalian Biologics CDMO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Mammalian Biologics CDMO Services Product and Solutions
Table 8. Lonza Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Mammalian Biologics CDMO Services Product and Solutions
Table 13. Catalent Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 16. Samsung Biologics Major Business
Table 17. Samsung Biologics Mammalian Biologics CDMO Services Product and Solutions
Table 18. Samsung Biologics Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 20. FUJIFILM Diosynth Biotechnologies Major Business
Table 21. FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Product and Solutions
Table 22. FUJIFILM Diosynth Biotechnologies Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 24. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 25. Boehringer Ingelheim Major Business
Table 26. Boehringer Ingelheim Mammalian Biologics CDMO Services Product and Solutions
Table 27. Boehringer Ingelheim Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Boehringer Ingelheim Recent Developments and Future Plans
Table 29. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 30. WuXi AppTech Major Business
Table 31. WuXi AppTech Mammalian Biologics CDMO Services Product and Solutions
Table 32. WuXi AppTech Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. WuXi AppTech Recent Developments and Future Plans
Table 34. Recipharm Company Information, Head Office, and Major Competitors
Table 35. Recipharm Major Business
Table 36. Recipharm Mammalian Biologics CDMO Services Product and Solutions
Table 37. Recipharm Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Recipharm Recent Developments and Future Plans
Table 39. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 40. Thermo Fisher Scientific Major Business
Table 41. Thermo Fisher Scientific Mammalian Biologics CDMO Services Product and Solutions
Table 42. Thermo Fisher Scientific Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Thermo Fisher Scientific Recent Developments and Future Plans
Table 44. AGC Biologics Company Information, Head Office, and Major Competitors
Table 45. AGC Biologics Major Business
Table 46. AGC Biologics Mammalian Biologics CDMO Services Product and Solutions
Table 47. AGC Biologics Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. AGC Biologics Recent Developments and Future Plans
Table 49. Rentschler Biopharma Company Information, Head Office, and Major Competitors
Table 50. Rentschler Biopharma Major Business
Table 51. Rentschler Biopharma Mammalian Biologics CDMO Services Product and Solutions
Table 52. Rentschler Biopharma Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Rentschler Biopharma Recent Developments and Future Plans
Table 54. KBI Biopharma Company Information, Head Office, and Major Competitors
Table 55. KBI Biopharma Major Business
Table 56. KBI Biopharma Mammalian Biologics CDMO Services Product and Solutions
Table 57. KBI Biopharma Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. KBI Biopharma Recent Developments and Future Plans
Table 59. Siegfried Company Information, Head Office, and Major Competitors
Table 60. Siegfried Major Business
Table 61. Siegfried Mammalian Biologics CDMO Services Product and Solutions
Table 62. Siegfried Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Siegfried Recent Developments and Future Plans
Table 64. Aenova Group Company Information, Head Office, and Major Competitors
Table 65. Aenova Group Major Business
Table 66. Aenova Group Mammalian Biologics CDMO Services Product and Solutions
Table 67. Aenova Group Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Aenova Group Recent Developments and Future Plans
Table 69. GenScript Company Information, Head Office, and Major Competitors
Table 70. GenScript Major Business
Table 71. GenScript Mammalian Biologics CDMO Services Product and Solutions
Table 72. GenScript Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. GenScript Recent Developments and Future Plans
Table 74. ProBioGen Company Information, Head Office, and Major Competitors
Table 75. ProBioGen Major Business
Table 76. ProBioGen Mammalian Biologics CDMO Services Product and Solutions
Table 77. ProBioGen Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. ProBioGen Recent Developments and Future Plans
Table 79. Northway Biotech Company Information, Head Office, and Major Competitors
Table 80. Northway Biotech Major Business
Table 81. Northway Biotech Mammalian Biologics CDMO Services Product and Solutions
Table 82. Northway Biotech Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Northway Biotech Recent Developments and Future Plans
Table 84. 3P Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 85. 3P Biopharmaceuticals Major Business
Table 86. 3P Biopharmaceuticals Mammalian Biologics CDMO Services Product and Solutions
Table 87. 3P Biopharmaceuticals Mammalian Biologics CDMO Services Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. 3P Biopharmaceuticals Recent Developments and Future Plans
Table 89. Global Mammalian Biologics CDMO Services Revenue (USD Million) by Players (2020-2025)
Table 90. Global Mammalian Biologics CDMO Services Revenue Share by Players (2020-2025)
Table 91. Breakdown of Mammalian Biologics CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Mammalian Biologics CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 93. Head Office of Key Mammalian Biologics CDMO Services Players
Table 94. Mammalian Biologics CDMO Services Market: Company Product Type Footprint
Table 95. Mammalian Biologics CDMO Services Market: Company Product Application Footprint
Table 96. Mammalian Biologics CDMO Services New Market Entrants and Barriers to Market Entry
Table 97. Mammalian Biologics CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Mammalian Biologics CDMO Services Consumption Value (USD Million) by Type (2020-2025)
Table 99. Global Mammalian Biologics CDMO Services Consumption Value Share by Type (2020-2025)
Table 100. Global Mammalian Biologics CDMO Services Consumption Value Forecast by Type (2026-2031)
Table 101. Global Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025)
Table 102. Global Mammalian Biologics CDMO Services Consumption Value Forecast by Application (2026-2031)
Table 103. North America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 104. North America Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 105. North America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 106. North America Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 107. North America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 110. Europe Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 111. Europe Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 112. Europe Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 113. Europe Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 114. Europe Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 115. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 116. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 117. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2020-2025) & (USD Million)
Table 120. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value by Region (2026-2031) & (USD Million)
Table 121. South America Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 122. South America Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 123. South America Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 124. South America Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 125. South America Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 126. South America Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 127. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2020-2025) & (USD Million)
Table 128. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Type (2026-2031) & (USD Million)
Table 129. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2020-2025) & (USD Million)
Table 130. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Application (2026-2031) & (USD Million)
Table 131. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2020-2025) & (USD Million)
Table 132. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Global Key Players of Mammalian Biologics CDMO Services Upstream (Raw Materials)
Table 134. Global Mammalian Biologics CDMO Services Typical Customers
LIST OF FIGURES
Figure 1. Mammalian Biologics CDMO Services Picture
Figure 2. Global Mammalian Biologics CDMO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Type in 2024
Figure 4. Cell and Gene Therapies
Figure 5. Antibodies
Figure 6. Vaccines
Figure 7. Other
Figure 8. Global Mammalian Biologics CDMO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Mammalian Biologics CDMO Services Consumption Value Market Share by Application in 2024
Figure 10. SMBs Picture
Figure 11. Large Companies Picture
Figure 12. Global Mammalian Biologics CDMO Services Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Mammalian Biologics CDMO Services Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Mammalian Biologics CDMO Services Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Region in 2024
Figure 17. North America Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Mammalian Biologics CDMO Services Revenue Share by Players in 2024
Figure 24. Mammalian Biologics CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Mammalian Biologics CDMO Services by Player Revenue in 2024
Figure 26. Top 3 Mammalian Biologics CDMO Services Players Market Share in 2024
Figure 27. Top 6 Mammalian Biologics CDMO Services Players Market Share in 2024
Figure 28. Global Mammalian Biologics CDMO Services Consumption Value Share by Type (2020-2025)
Figure 29. Global Mammalian Biologics CDMO Services Market Share Forecast by Type (2026-2031)
Figure 30. Global Mammalian Biologics CDMO Services Consumption Value Share by Application (2020-2025)
Figure 31. Global Mammalian Biologics CDMO Services Market Share Forecast by Application (2026-2031)
Figure 32. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 42. France Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Region (2020-2031)
Figure 49. China Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 52. India Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 66. Mammalian Biologics CDMO Services Market Drivers
Figure 67. Mammalian Biologics CDMO Services Market Restraints
Figure 68. Mammalian Biologics CDMO Services Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Mammalian Biologics CDMO Services Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Mammalian Biologics CDMO Services Picture
Figure 2. Global Mammalian Biologics CDMO Services Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Type in 2024
Figure 4. Cell and Gene Therapies
Figure 5. Antibodies
Figure 6. Vaccines
Figure 7. Other
Figure 8. Global Mammalian Biologics CDMO Services Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Mammalian Biologics CDMO Services Consumption Value Market Share by Application in 2024
Figure 10. SMBs Picture
Figure 11. Large Companies Picture
Figure 12. Global Mammalian Biologics CDMO Services Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Mammalian Biologics CDMO Services Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Mammalian Biologics CDMO Services Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Mammalian Biologics CDMO Services Consumption Value Market Share by Region in 2024
Figure 17. North America Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Mammalian Biologics CDMO Services Revenue Share by Players in 2024
Figure 24. Mammalian Biologics CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Mammalian Biologics CDMO Services by Player Revenue in 2024
Figure 26. Top 3 Mammalian Biologics CDMO Services Players Market Share in 2024
Figure 27. Top 6 Mammalian Biologics CDMO Services Players Market Share in 2024
Figure 28. Global Mammalian Biologics CDMO Services Consumption Value Share by Type (2020-2025)
Figure 29. Global Mammalian Biologics CDMO Services Market Share Forecast by Type (2026-2031)
Figure 30. Global Mammalian Biologics CDMO Services Consumption Value Share by Application (2020-2025)
Figure 31. Global Mammalian Biologics CDMO Services Market Share Forecast by Application (2026-2031)
Figure 32. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 42. France Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Mammalian Biologics CDMO Services Consumption Value Market Share by Region (2020-2031)
Figure 49. China Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 52. India Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Mammalian Biologics CDMO Services Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Mammalian Biologics CDMO Services Consumption Value (2020-2031) & (USD Million)
Figure 66. Mammalian Biologics CDMO Services Market Drivers
Figure 67. Mammalian Biologics CDMO Services Market Restraints
Figure 68. Mammalian Biologics CDMO Services Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Mammalian Biologics CDMO Services Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
